Fecal microbiota transplantation improves hepatic steatosis induced by HFD in a mouse model associated with liver ILC1 regulation and indole-3-carbinol level

Fecal microbiota transplantation improves hepatic steatosis induced by HFD in a mouse model associated with liver ILC1 regulation and indole-3-carbinol level

BackgroundThe prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) has increased worldwide. In recent years, fecal microbiota transplantation (FMT) has become an important promising method for the treatment of MASLD. However, the mechanism remains unclear.MethodsThe animal...

Full description

Saved in:

Bibliographic Details
Main Authors:	Peng-fei Hou, Yu Yao, Ying Wu, Hong-tao Yu, Yu Qin, Long Yi, Man-tian Mi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Nutrition
Subjects:	metabolic dysfunction-associated steatotic liver disease liver ILC1 fecal microbiota transplantation Indole-3-carbinol aryl hydrocarbon receptor high-fat diet
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2025.1500293/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Indole-3-Carbinol Enhances Alternative Activation of Macrophages via AHR Pathway and Glucose Transporter Regulation
by: Delara Omrani, et al.
Published: (2025-05-01)

Unveiling the Multifaceted Pharmacological Actions of Indole-3-Carbinol and Diindolylmethane: A Comprehensive Review
by: Yadava Srikanth, et al.
Published: (2025-03-01)

Indole-3-carbinol alleviates allergic skin inflammation via periostin/thymic stromal lymphopoietin suppression in atopic dermatitis
by: Yun-Mi Kang, et al.
Published: (2024-12-01)

Potential of Indole-3-Carbinol compounds from broccoli (Brassica oleracea var. italica) as natural aromatase blockers: In silico prediction and in vivo studies
by: Reski Amalia, et al.
Published: (2025-04-01)

Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice
by: XuWen Mao, et al.
Published: (2025-01-01)

Investigation of the Roles of Phosphatidylinositol 4-Phosphate 5-Kinases 7,9 and Wall-Associated Kinases 1–3 in Responses to Indole-3-Carbinol and Biotic Stress in Arabidopsis Thaliana
by: Hala Khamesa-Israelov, et al.
Published: (2024-10-01)

Indole derivatives ameliorated the methamphetamine-induced depression and anxiety via aryl hydrocarbon receptor along “microbiota-brain” axis
by: Xi Wang, et al.
Published: (2025-12-01)

Reproducibility of ultrasound-derived fat fraction in measuring hepatic steatosis
by: Danlei Song, et al.
Published: (2024-10-01)

Dendritic Cells Promote the Differentiation of ILCs into NCR−ILC3s in the Lungs of Mice Exposed to Cigarette Smoke
by: Caixia Liang, et al.
Published: (2024-12-01)

The gut commensal Faecalibacterium hominis attenuates indole—AhR signaling and restores ASD—like behaviors with BTBR mice
by: You Yu, et al.
Published: (2025-08-01)

Liver Stiffness, Not Steatosis, Predicts Mortality in MASLD Patients: An NHANES Analysis
by: Yuting Huang, et al.
Published: (2024-12-01)

Serum metabolites characterize hepatic phenotypes and reveal shared pathways: results from population-based imaging
by: Juliane Maushagen, et al.
Published: (2025-07-01)

Periodontal diseases, potential mediators and development of liver fat content: a community-based large cohort
by: Bofu Liu, et al.
Published: (2025-04-01)

How exercise shapes the anti-inflammatory environment in multiple sclerosis – a conceptual framework focusing on tryptophan-derived molecules in T cell differentiation
by: Wences Chirino Tiffany Y., et al.
Published: (2024-12-01)

Rapid access to diverse indoles by addition/SNAr with Grignard reagents and 2-fluorophenyl acetonitriles
by: Yuanyun Gu, et al.
Published: (2025-05-01)

Impact of hepatic steatosis on liver stiffness measurement by vibration-controlled transient elastography and its diagnostic performance for identifying liver fibrosis in patients with chronic hepatitis B
by: Zhiyuan Chen, et al.
Published: (2024-11-01)

Expression of steroid hormones receptors and morphofunctional condition endometrium at patients with anomalous uterine bleedings
by: I. P. Tayukina, et al.
Published: (2009-04-01)

Mastalgia: current trends and recommendations
by: A. I. Berishvili, et al.
Published: (2024-05-01)

Asymmetric Synthesis of Dialkyl Carbinols by Ni‐Catalyzed Reductive‐Oxidative Relay of Distinct Alkenes
by: Quan‐Xing Zi, et al.
Published: (2024-12-01)

The association of chronic pain, painkiller use, and potential mediators with liver fat content
by: Yu Cheng, et al.
Published: (2025-02-01)

Novel cross-feeding human gut microbes metabolizing tryptophan to indole-3-propionate
by: Janina N. Zünd, et al.
Published: (2025-12-01)

Augmenter of Liver Regeneration Crotonylation Assists in Mitochondria-ER Contact to Alleviate Hepatic SteatosisSummary
by: Xiao-lin Wang, et al.
Published: (2025-01-01)

Association between AHR in EGCs and IBS-D patients: the indole pathway of tryptophan metabolism
by: Lianli Wang, et al.
Published: (2025-03-01)

State Estimators for Plants Implementing ILC Strategies through Delay Links
by: Lina Si, et al.
Published: (2024-09-01)

Perirenal fat thickness is an independent predictor for metabolic syndrome in steatotic liver disease
by: Jong Wook Choi, et al.
Published: (2024-11-01)

Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019
by: Jacob Romano, et al.
Published: (2025-01-01)

Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level
by: Reza Hakkak, et al.
Published: (2024-10-01)

Attenuation Based Quantitative Evaluation of Hepatic Steatosis Using US: Current Status and Future Perspective
by: Dong Ho Lee
Published: (2025-05-01)

LKB1 regulates ILC3 postnatal development and effector function through metabolic programming
by: Huasheng Zhang, et al.
Published: (2025-06-01)

Chronic Inflammation and Immune Dysregulation in Metabolic-Dysfunction-Associated Steatotic Liver Disease Progression: From Steatosis to Hepatocellular Carcinoma
by: Young-Min Jee, et al.
Published: (2025-05-01)

Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis
by: Zhifeng Fang, et al.
Published: (2022-12-01)

Halk Kütüphanelerinde Halkla İlişkiler ve Narlıdere İlçe Halk Kütüphanesi Örneği
by: Mehmet Ali Akkaya
Published: (2013-11-01)

Evaluation of bioaccessibility, metabolic clearance and interaction with xenobiotic receptors (PXR and AhR) of cinnamaldehyde
by: Islam Husain, et al.
Published: (2025-06-01)

Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience
by: Thanikan Sukaram, et al.
Published: (2025-01-01)

Gut microbiota links to histological damage in chronic HBV infection patients and aggravates fibrosis via fecal microbiota transplantation in mice
by: Fengjiao Wang, et al.
Published: (2025-08-01)

Association between polycyclic aromatic hydrocarbons exposure and metabolic dysfunction-associated steatotic liver disease in US adults
by: Jiajun Wu, et al.
Published: (2025-06-01)

ILC3 Function as a Double-Edged Sword in EV71 Infection
by: Chang Zhang, et al.
Published: (2025-01-01)

Association and dynamic change of fecal calprotectin with sepsis associated liver dysfunction in adults with sepsis
by: Beiyuan Zhang, et al.
Published: (2025-05-01)

Effects of hepatic fibrosis on the quantification of hepatic steatosis using the controlled attenuation parameter in patients with chronic hepatitis B
by: Hee Jun Park, et al.
Published: (2025-01-01)

DL-Tryptophan Alleviates Sepsis-Related Acute Liver Injury via AhR Activation
by: Li B, et al.
Published: (2025-07-01)